Yvoire Dermal Filler: A Professional Market Update on the LG Chem Business Sale and North American Expansion

In a significant market development, LG Chem has sold its dermal filler business, including the Yvoire brand, to private equity firm VIG Partners. As reported by sources including KED Global and BeautyMatter in late 2025, the transaction was valued at approximately $144 million.

This acquisition signals a new phase for the Yvoire portfolio. For clinic owners and distributors, such changes in ownership can influence future product development, brand strategy, and international distribution networks. The move allows LG Chem to concentrate on other core business areas while VIG Partners is expected to focus on expanding the aesthetic division's global footprint.

Prior to the acquisition, LG Chem announced its official entry into the Canadian aesthetic filler market with the Yvoire brand in December 2024. This marked a milestone for the company, making it the first Korean entity to launch a dermal filler in Canada, according to LG Corp and KBR reports.

Health Canada's approval provides Canadian aesthetic practitioners with a new option for their clinics. This strategic expansion into a major North American market underscores the brand's growing international recognition and regulatory acceptance. For professionals sourcing products, this move may indicate a robust quality management system and adherence to stringent regulatory standards.

Yvoire Classic is a hyaluronic acid-based dermal filler developed and manufactured by LG Chem in South Korea. It is formulated using the company's HICE (High Concentration Equalized) cross-linking technology. This technology aims to achieve a high concentration of hyaluronic acid while minimizing the amount of cross-linking agent used, resulting in a specific rheological profile.

Designed for professional use, Yvoire Classic is typically supplied in a pre-filled 1mL syringe. When evaluating its place in a clinical offering, practitioners often compare its specifications against other established products. The broader Hyaluronic acid dermal filler catalog offers a range of alternatives with varying properties to meet diverse clinical needs.

The dual news of a major acquisition and North American expansion creates new considerations for aesthetic clinics. The backing of a private equity firm often precedes aggressive market growth, which could mean increased marketing support and a more stable supply chain for Yvoire products. Clinics currently offering or considering Yvoire should monitor communications from the new ownership for any updates on distribution channels and product support.

Diversifying a clinic's portfolio is a standard business practice. Sourcing guides that compare different fillers, such as this D.Fill Medium vs. Hyaldew vs. Elasty Plus review, can help professionals make informed decisions about which products best suit their practice and client base.

For procurement managers and clinic owners, understanding the wholesale pricing structure is critical. An illustrative unit price for Yvoire Classic is $79.80. Volume-based discounts are standard in the B2B sector, allowing larger practices and distributors to optimize procurement costs. A typical tiered structure might be:

These tiers reward bulk purchasing and are a key factor when forecasting inventory costs. Professionals looking to stock similar Korean-made products can also review options like D.Fill Medium to compare cost-effectiveness and product characteristics.